{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T23:48:57Z","timestamp":1792540137035,"version":"4.5.0"},"reference-count":64,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T00:00:00Z","timestamp":1737936000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100004366","name":"Tabriz University of Medical Sciences","doi-asserted-by":"publisher","award":["68799"],"award-info":[{"award-number":["68799"]}],"id":[{"id":"10.13039\/501100004366","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Neurochem Res"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1007\/s11064-025-04338-6","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T05:39:50Z","timestamp":1737956390000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Varenicline Attenuates Memory Impairment in Amyloid-Beta-Induced Rat Model of Alzheimer\u2019s Disease"],"prefix":"10.1007","volume":"50","author":[{"given":"Seyed Zanyar","family":"Athari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sareh","family":"Kazmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyed Mehdi","family":"Vatandoust","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Mahmoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereshteh","family":"Farajdokht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatemeh","family":"Hajihosseinlou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedram","family":"Ghaderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Majdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Sadigh-Eteghad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,1,27]]},"reference":[{"key":"4338_CR1","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.jep.2012.07.019","volume":"143","author":"SJ Park","year":"2012","unstructured":"Park SJ, Jung JM, Lee HE, Lee YW, Kim DH, Kim JM, Hong JG, Lee CH, Jung IH, Cho YB, Jang DS, Ryu JH (2012) The memory ameliorating effects of INM-176, an ethanolic extract of Angelica Gigas, against scopolamine- or A\u03b2(1\u201342)-induced cognitive dysfunction in mice. J Ethnopharmacol 143:611\u2013620","journal-title":"J Ethnopharmacol"},{"key":"4338_CR2","doi-asserted-by":"publisher","first-page":"722","DOI":"10.1016\/j.neuropharm.2009.12.020","volume":"58","author":"AL Fu","year":"2010","unstructured":"Fu AL, Zhou CY, Chen X (2010) Thyroid hormone prevents cognitive deficit in a mouse model of Alzheimer\u2019s disease. Neuropharmacology 58:722\u2013729","journal-title":"Neuropharmacology"},{"key":"4338_CR3","doi-asserted-by":"publisher","first-page":"624302","DOI":"10.3389\/fmolb.2021.624302","volume":"8","author":"C Leonard","year":"2021","unstructured":"Leonard C, Phillips C, McCarty J (2021) Insight into seeded tau Fibril Growth from Molecular Dynamics Simulation of the Alzheimer\u2019s Disease Protofibril Core. Front Mol Biosci 8:624302","journal-title":"Front Mol Biosci"},{"key":"4338_CR4","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1186\/s13024-019-0333-5","volume":"14","author":"MA DeTure","year":"2019","unstructured":"DeTure MA, Dickson DW (2019) The neuropathological diagnosis of Alzheimer\u2019s disease. Mol Neurodegeneration 14:32","journal-title":"Mol Neurodegeneration"},{"key":"4338_CR5","doi-asserted-by":"publisher","first-page":"1082158","DOI":"10.3389\/fnbeh.2022.1082158","volume":"16","author":"A Silva","year":"2022","unstructured":"Silva A, Mart\u00ednez MC (2022) Spatial memory deficits in Alzheimer\u2019s disease and their connection to cognitive maps\u2019 formation by place cells and grid cells. Front Behav Neurosci 16:1082158","journal-title":"Front Behav Neurosci"},{"key":"4338_CR6","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1016\/j.neuron.2020.06.023","volume":"107","author":"H Jun","year":"2020","unstructured":"Jun H, Bramian A, Soma S, Saito T, Saido TC, Igarashi KM (2020) Disrupted place cell remapping and impaired Grid cells in a Knockin Model of Alzheimer\u2019s Disease. Neuron 107:1095\u20131112e1096","journal-title":"Neuron"},{"key":"4338_CR7","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12989-019-0323-3","volume":"16","author":"K Jew","year":"2019","unstructured":"Jew K, Herr D, Wong C, Kennell A, Morris-Schaffer K, Oberd\u00f6rster G, O\u2019Banion MK, Cory-Slechta DA, Elder A (2019) Selective memory and behavioral alterations after ambient ultrafine particulate matter exposure in aged 3xTgAD Alzheimer\u2019s disease mice. Part Fibre Toxicol 16:45","journal-title":"Part Fibre Toxicol"},{"key":"4338_CR8","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.nicl.2013.08.017","volume":"3","author":"A Badhwar","year":"2013","unstructured":"Badhwar A, Lerch JP, Hamel E, Sled JG (2013) Impaired structural correlates of memory in Alzheimer\u2019s disease mice. Neuroimage Clin 3:290\u2013300","journal-title":"Neuroimage Clin"},{"key":"4338_CR9","doi-asserted-by":"publisher","first-page":"e12712","DOI":"10.1111\/gbb.12712","volume":"20","author":"BB Tournier","year":"2021","unstructured":"Tournier BB, Barca C, Fall AB, Gloria Y, Meyer L, Ceyz\u00e9riat K, Millet P (2021) Spatial reference learning deficits in absence of dysfunctional working memory in the TgF344-AD rat model of Alzheimer\u2019s disease. Genes Brain Behav 20:e12712","journal-title":"Genes Brain Behav"},{"key":"4338_CR10","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1016\/j.neurobiolaging.2007.10.001","volume":"30","author":"E Head","year":"2009","unstructured":"Head E, Corrada MM, Kahle-Wrobleski K, Kim RC, Sarsoza F, Goodus M, Kawas CH (2009) Synaptic proteins, neuropathology and cognitive status in the oldest-old. Neurobiol Aging 30:1125\u20131134","journal-title":"Neurobiol Aging"},{"key":"4338_CR11","doi-asserted-by":"publisher","first-page":"3292","DOI":"10.1016\/j.cub.2021.05.039","volume":"31","author":"O Rechnitz","year":"2021","unstructured":"Rechnitz O, Slutsky I, Morris G, Derdikman D (2021) Hippocampal sub-networks exhibit distinct spatial representation deficits in Alzheimer\u2019s disease model mice. Curr Biol 31:3292\u20133302e3296","journal-title":"Curr Biol"},{"key":"4338_CR12","doi-asserted-by":"publisher","first-page":"4466","DOI":"10.1038\/s41467-023-40208-x","volume":"14","author":"M Askenazi","year":"2023","unstructured":"Askenazi M, Kavanagh T, Pires G, Ueberheide B, Wisniewski T, Drummond E (2023) Compilation of reported protein changes in the brain in Alzheimer\u2019s disease. Nat Commun 14:4466","journal-title":"Nat Commun"},{"key":"4338_CR13","doi-asserted-by":"publisher","first-page":"595583","DOI":"10.3389\/fnins.2021.595583","volume":"15","author":"PC Bello-Medina","year":"2021","unstructured":"Bello-Medina PC, Hern\u00e1ndez-Quiroz F, P\u00e9rez-Morales M, Gonz\u00e1lez-Franco DA, Cruz-Pauseno G, Garc\u00eda-Mena J, D\u00edaz-Cintra S, Pacheco-L\u00f3pez G (2021) Spatial memory and gut microbiota alterations are already Present in Early Adulthood in a pre-clinical transgenic model of Alzheimer\u2019s Disease. Front Neurosci 15:595583","journal-title":"Front Neurosci"},{"key":"4338_CR14","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.neurobiolaging.2019.09.008","volume":"85","author":"C Babiloni","year":"2020","unstructured":"Babiloni C, Blinowska K, Bonanni L, Cichocki A, De Haan W, Del Percio C, Dubois B, Escudero J, Fern\u00e1ndez A, Frisoni G (2020) What electrophysiology tells us about Alzheimer\u2019s disease: a window into the synchronization and connectivity of brain neurons. Neurobiol Aging 85:58\u201373","journal-title":"Neurobiol Aging"},{"key":"4338_CR15","doi-asserted-by":"publisher","first-page":"2716","DOI":"10.1093\/cercor\/bhy140","volume":"29","author":"M Stoiljkovic","year":"2019","unstructured":"Stoiljkovic M, Kelley C, Stutz B, Horvath TL, Haj\u00f3s M (2019) Altered cortical and hippocampal excitability in TgF344-AD rats modeling Alzheimer\u2019s disease pathology. Cereb Cortex 29:2716\u20132727","journal-title":"Cereb Cortex"},{"key":"4338_CR16","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1016\/j.brs.2018.10.009","volume":"12","author":"F Di Lorenzo","year":"2019","unstructured":"Di Lorenzo F, Motta C, Bonn\u00ec S, Mercuri NB, Caltagirone C, Martorana A, Koch G (2019) LTP-like cortical plasticity is associated with verbal memory impairment in Alzheimer\u2019s disease patients. Brain Stimul 12:148\u2013151","journal-title":"Brain Stimul"},{"key":"4338_CR17","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1038\/nrn.2016.141","volume":"17","author":"JJ Palop","year":"2016","unstructured":"Palop JJ, Mucke L (2016) Network abnormalities and interneuron dysfunction in Alzheimer disease. Nat Rev Neurosci 17:777\u2013792","journal-title":"Nat Rev Neurosci"},{"key":"4338_CR18","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1016\/j.ijpsycho.2015.02.008","volume":"103","author":"C Babiloni","year":"2016","unstructured":"Babiloni C, Lizio R, Marzano N, Capotosto P, Soricelli A, Triggiani AI, Cordone S, Gesualdo L, Del Percio C (2016) Brain neural synchronization and functional coupling in Alzheimer\u2019s disease as revealed by resting state EEG rhythms. Int J Psychophysiol 103:88\u2013102","journal-title":"Int J Psychophysiol"},{"key":"4338_CR19","doi-asserted-by":"crossref","unstructured":"Weller J, Budson A (2018) Current understanding of Alzheimer\u2019s disease diagnosis and treatment. F1000Res 7","DOI":"10.12688\/f1000research.14506.1"},{"key":"4338_CR20","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1186\/s40001-023-01512-w","volume":"28","author":"W Wu","year":"2023","unstructured":"Wu W, Ji Y, Wang Z, Wu X, Li J, Gu F, Chen Z, Wang Z (2023) The FDA-approved anti-amyloid-\u03b2 monoclonal antibodies for the treatment of Alzheimer\u2019s disease: a systematic review and meta-analysis of randomized controlled trials. Eur J Med Res 28:544","journal-title":"Eur J Med Res"},{"key":"4338_CR21","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1124\/mol.106.025130","volume":"70","author":"KB Mihalak","year":"2006","unstructured":"Mihalak KB, Carroll FI, Luetje CW (2006) Varenicline is a partial agonist at \u03b14\u03b22 and a full agonist at \u03b17 neuronal nicotinic receptors. Mol Pharmacol 70:801\u2013805","journal-title":"Mol Pharmacol"},{"key":"4338_CR22","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1016\/j.biopsych.2010.01.016","volume":"67","author":"J Loughead","year":"2010","unstructured":"Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S, Gur RC, Lerman C (2010) Effects of the \u03b14\u03b22 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biol Psychiatry 67:715\u2013721","journal-title":"Biol Psychiatry"},{"key":"4338_CR23","doi-asserted-by":"publisher","first-page":"813","DOI":"10.1016\/j.bcp.2009.05.033","volume":"78","author":"H Rollema","year":"2009","unstructured":"Rollema H, Haj\u00f3s M, Seymour PA, Kozak R, Majchrzak MJ, Guanowsky V, Horner WE, Chapin DS, Hoffmann WE, Johnson DE (2009) Preclinical pharmacology of the \u03b14\u03b22 nAChR partial agonist varenicline related to effects on reward, mood and cognition. Biochem Pharmacol 78:813\u2013824","journal-title":"Biochem Pharmacol"},{"key":"4338_CR24","doi-asserted-by":"publisher","first-page":"109672","DOI":"10.1016\/j.neuropharm.2023.109672","volume":"239","author":"H Esaki","year":"2023","unstructured":"Esaki H, Deyama S, Izumi S, Katsura A, Nishikawa K, Nishitani N, Kaneda K (2023) Varenicline enhances recognition memory via \u03b17 nicotinic acetylcholine receptors in the medial prefrontal cortex in male mice. Neuropharmacology 239:109672","journal-title":"Neuropharmacology"},{"key":"4338_CR25","doi-asserted-by":"publisher","first-page":"761","DOI":"10.1007\/s00213-015-4154-0","volume":"233","author":"AV Terry","year":"2016","unstructured":"Terry AV, Plagenhoef M, Callahan PM (2016) Effects of the nicotinic agonist varenicline on the performance of tasks of cognition in aged and middle-aged rhesus and pigtail monkeys. Psychopharmacology 233:761\u2013771","journal-title":"Psychopharmacology"},{"key":"4338_CR26","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1159\/000355373","volume":"37","author":"SY Kim","year":"2014","unstructured":"Kim SY, Choi SH, Rollema H, Schwam EM, McRae T, Dubrava S, Jacobsen J (2014) Phase II crossover trial of varenicline in mild-to-moderate Alzheimer\u2019s disease. Dement Geriatr Cogn Disord 37:232\u2013245","journal-title":"Dement Geriatr Cogn Disord"},{"key":"4338_CR27","unstructured":"Paxinos G, Watson C (2006) The rat brain in stereotaxic coordinates: 6th edition. Elsevier"},{"key":"4338_CR28","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.brainresbull.2022.01.010","volume":"181","author":"F Seyedaghamiri","year":"2022","unstructured":"Seyedaghamiri F, Hosseini L, Kazmi S, Mahmoudi J, Shanehbandi D, Ebrahimi-Kalan A, Rahbarghazi R, Sadigh-Eteghad S, Farhoudi M (2022) Varenicline improves cognitive impairment in a mouse model of mPFC ischemia: the possible roles of inflammation, apoptosis, and synaptic factors. Brain Res Bull 181:36\u201345","journal-title":"Brain Res Bull"},{"key":"4338_CR29","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13287-022-03024-6","volume":"13","author":"G Bahlakeh","year":"2022","unstructured":"Bahlakeh G, Rahbarghazi R, Abedelahi A, Sadigh-Eteghad S, Karimipour M (2022) Neurotrophic factor-secreting cells restored endogenous hippocampal neurogenesis through the Wnt\/\u03b2-catenin signaling pathway in AD model mice. Stem Cell Res Ther 13:1\u201314","journal-title":"Stem Cell Res Ther"},{"key":"4338_CR30","doi-asserted-by":"publisher","first-page":"21177","DOI":"10.1038\/s41598-021-00402-7","volume":"11","author":"R d\u2019Isa","year":"2021","unstructured":"d\u2019Isa R, Comi G, Leocani L (2021) Apparatus design and behavioural testing protocol for the evaluation of spatial working memory in mice through the spontaneous alternation T-maze. Sci Rep 11:21177","journal-title":"Sci Rep"},{"key":"4338_CR31","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.bbr.2008.10.029","volume":"198","author":"SS Patil","year":"2009","unstructured":"Patil SS, Sunyer B, H\u00f6ger H, Lubec G (2009) Evaluation of spatial memory of C57BL\/6J and CD1 mice in the Barnes maze, the multiple T-maze and in the Morris water maze. Behav Brain Res 198:58\u201368","journal-title":"Behav Brain Res"},{"key":"4338_CR32","doi-asserted-by":"publisher","first-page":"118018","DOI":"10.1016\/j.lfs.2020.118018","volume":"256","author":"HH Dastgerdi","year":"2020","unstructured":"Dastgerdi HH, Radahmadi M, Reisi P (2020) Comparative study of the protective effects of crocin and exercise on long-term potentiation of CA1 in rats under chronic unpredictable stress. Life Sci 256:118018","journal-title":"Life Sci"},{"key":"4338_CR33","first-page":"730","volume":"30","author":"R Benavides-Piccione","year":"2020","unstructured":"Benavides-Piccione R, Regalado-Reyes M, Fernaud-Espinosa I, Kastanauskaite A, Tapia-Gonz\u00e1lez S, Le\u00f3n-Espinosa G, Rojo C, Insausti R, Segev I, DeFelipe J (2020) Differential structure of hippocampal CA1 pyramidal neurons in the human and Mouse. Cereb Cortex 30:730\u2013752","journal-title":"Cereb Cortex"},{"key":"4338_CR34","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1016\/j.neuron.2012.09.036","volume":"76","author":"AR Graves","year":"2012","unstructured":"Graves AR, Moore SJ, Bloss EB, Mensh BD, Kath WL, Spruston N (2012) Hippocampal pyramidal neurons comprise two distinct cell types that are countermodulated by metabotropic receptors. Neuron 76:776\u2013789","journal-title":"Neuron"},{"key":"4338_CR35","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.nlm.2015.02.001","volume":"119","author":"E Riahi","year":"2015","unstructured":"Riahi E, Arezoomandan R, Fatahi Z, Haghparast A (2015) The electrical activity of hippocampal pyramidal neuron is subjected to descending control by the brain orexin\/hypocretin system. Neurobiol Learn Mem 119:93\u2013101","journal-title":"Neurobiol Learn Mem"},{"key":"4338_CR36","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.brainresbull.2020.08.010","volume":"164","author":"S Sadigh-Eteghad","year":"2020","unstructured":"Sadigh-Eteghad S, Vatandoust SM, Mahmoudi J, Rahigh Aghsan S, Majdi A (2020) Cotinine ameliorates memory and learning impairment in senescent mice. Brain Res Bull 164:65\u201374","journal-title":"Brain Res Bull"},{"key":"4338_CR37","doi-asserted-by":"publisher","first-page":"40753","DOI":"10.1038\/srep40753","volume":"7","author":"FU Amin","year":"2017","unstructured":"Amin FU, Shah SA, Kim MO (2017) Vanillic acid attenuates A\u03b2(1\u201342)-induced oxidative stress and cognitive impairment in mice. Sci Rep 7:40753","journal-title":"Sci Rep"},{"key":"4338_CR38","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.bbi.2016.03.002","volume":"56","author":"LC Souza","year":"2016","unstructured":"Souza LC, Jesse CR, Antunes MS, Ruff JR, de Oliveira Espinosa D, Gomes NS, Donato F, Giacomeli R, Boeira SP (2016) Indoleamine-2,3-dioxygenase mediates neurobehavioral alterations induced by an intracerebroventricular injection of amyloid-\u03b21\u201342 peptide in mice. Brain Behav Immun 56:363\u2013377","journal-title":"Brain Behav Immun"},{"key":"4338_CR39","doi-asserted-by":"publisher","first-page":"413","DOI":"10.3233\/JAD-2012-112192","volume":"30","author":"J Pearson-Leary","year":"2012","unstructured":"Pearson-Leary J, McNay EC (2012) Intrahippocampal administration of amyloid-\u03b2(1\u201342) oligomers acutely impairs spatial working memory, insulin signaling, and hippocampal metabolism. J Alzheimers Dis 30:413\u2013422","journal-title":"J Alzheimers Dis"},{"key":"4338_CR40","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1016\/j.bbi.2016.10.012","volume":"60","author":"C Balducci","year":"2017","unstructured":"Balducci C, Frasca A, Zotti M, La Vitola P, Mhillaj E, Grigoli E, Iacobellis M, Grandi F, Messa M, Colombo L, Molteni M, Trabace L, Rossetti C, Salmona M, Forloni G (2017) Toll-like receptor 4-dependent glial cell activation mediates the impairment in memory establishment induced by \u03b2-amyloid oligomers in an acute mouse model of Alzheimer\u2019s disease. Brain Behav Immun 60:188\u2013197","journal-title":"Brain Behav Immun"},{"key":"4338_CR41","doi-asserted-by":"publisher","first-page":"609005","DOI":"10.3389\/fnins.2020.609005","volume":"14","author":"TN Ho","year":"2020","unstructured":"Ho TN, Abraham N, Lewis RJ (2020) Structure-function of neuronal nicotinic acetylcholine receptor inhibitors derived from natural toxins. Front NeuroSci 14:609005","journal-title":"Front NeuroSci"},{"key":"4338_CR42","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s10254-003-0005-1","volume":"147","author":"RC Hogg","year":"2003","unstructured":"Hogg RC, Raggenbass M, Bertrand D (2003) Nicotinic acetylcholine receptors: from structure to brain function. Rev Physiol Biochem Pharmacol 147:1\u201346","journal-title":"Rev Physiol Biochem Pharmacol"},{"key":"4338_CR43","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1016\/bs.irn.2015.07.001","volume":"124","author":"JA Dani","year":"2015","unstructured":"Dani JA (2015) Neuronal nicotinic acetylcholine receptor structure and function and response to Nicotine. Int Rev Neurobiol 124:3\u201319","journal-title":"Int Rev Neurobiol"},{"key":"4338_CR44","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.neurobiolaging.2016.05.021","volume":"45","author":"M Stoiljkovic","year":"2016","unstructured":"Stoiljkovic M, Kelley C, Haj\u00f3s GP, Nagy D, Koenig G, Leventhal L, Haj\u00f3s M (2016) Hippocampal network dynamics in response to \u03b17 nACh receptors activation in amyloid-\u03b2 overproducing transgenic mice. Neurobiol Aging 45:161\u2013168","journal-title":"Neurobiol Aging"},{"key":"4338_CR45","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1016\/j.bcp.2015.07.006","volume":"97","author":"M Stoiljkovic","year":"2015","unstructured":"Stoiljkovic M, Leventhal L, Chen A, Chen T, Driscoll R, Flood D, Hodgdon H, Hurst R, Nagy D, Piser T (2015) Concentration-response relationship of the \u03b17 nicotinic acetylcholine receptor agonist FRM-17874 across multiple in vitro and in vivo assays. Biochem Pharmacol 97:576\u2013589","journal-title":"Biochem Pharmacol"},{"key":"4338_CR46","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1016\/j.bcp.2015.06.031","volume":"97","author":"M Stoiljkovic","year":"2015","unstructured":"Stoiljkovic M, Kelley C, Nagy D, Haj\u00f3s M (2015) Modulation of hippocampal neuronal network oscillations by \u03b17 nACh receptors. Biochem Pharmacol 97:445\u2013453","journal-title":"Biochem Pharmacol"},{"key":"4338_CR47","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.neuropharm.2016.03.025","volume":"107","author":"C Lange-Asschenfeldt","year":"2016","unstructured":"Lange-Asschenfeldt C, Sch\u00e4ble S, Suvorava T, Fahimi EG, Bisha M, Stermann T, Henning U, Kojda G (2016) Effects of varenicline on alpha4-containing nicotinic acetylcholine receptor expression and cognitive performance in mice. Neuropharmacology 107:100\u2013110","journal-title":"Neuropharmacology"},{"key":"4338_CR48","doi-asserted-by":"publisher","first-page":"194","DOI":"10.3389\/fnagi.2018.00194","volume":"10","author":"A Majdi","year":"2018","unstructured":"Majdi A, Sadigh-Eteghad S, Talebi M, Farajdokht F, Erfani M, Mahmoudi J, Gjedde A (2018) Nicotine modulates cognitive function in D-Galactose-Induced Senescence in mice. Front Aging Neurosci 10:194","journal-title":"Front Aging Neurosci"},{"key":"4338_CR49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1476-511X-12-113","volume":"12","author":"T Hajjar","year":"2013","unstructured":"Hajjar T, Goh YM, Rajion MA, Vidyadaran S, Li TA, Ebrahimi M (2013) Alterations in neuronal morphology and synaptophysin expression in the rat brain as a result of changes in dietary n-6: n-3 fatty acid ratios. Lipids Health Dis 12:1\u20139","journal-title":"Lipids Health Dis"},{"key":"4338_CR50","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fncel.2017.00266","volume":"11","author":"MR Holahan","year":"2017","unstructured":"Holahan MR (2017) A shift from a pivotal to supporting role for the growth-associated protein (GAP-43) in the coordination of axonal structural and functional plasticity. Front Cell Neurosci 11:266","journal-title":"Front Cell Neurosci"},{"key":"4338_CR51","doi-asserted-by":"publisher","first-page":"266","DOI":"10.3389\/fnins.2020.00266","volume":"14","author":"Y Vyas","year":"2020","unstructured":"Vyas Y, Montgomery JM, Cheyne JE (2020) Hippocampal deficits in Amyloid-\u03b2-Related rodent models of Alzheimer\u2019s Disease. Front Neurosci 14:266","journal-title":"Front Neurosci"},{"key":"4338_CR52","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1186\/s40478-018-0626-x","volume":"6","author":"S Li","year":"2018","unstructured":"Li S, Jin M, Liu L, Dang Y, Ostaszewski BL, Selkoe DJ (2018) Decoding the synaptic dysfunction of bioactive human AD brain soluble A\u03b2 to inspire novel therapeutic avenues for Alzheimer\u2019s disease. Acta Neuropathol Commun 6:121","journal-title":"Acta Neuropathol Commun"},{"key":"4338_CR53","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s40478-022-01350-7","volume":"10","author":"OA Shipton","year":"2022","unstructured":"Shipton OA, Tang CS, Paulsen O, Vargas-Caballero M (2022) Differential vulnerability of hippocampal CA3-CA1 synapses to A\u03b2. Acta Neuropathol Commun 10:45","journal-title":"Acta Neuropathol Commun"},{"key":"4338_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s13205-022-03123-4","volume":"12","author":"YL Rao","year":"2022","unstructured":"Rao YL, Ganaraja B, Murlimanju BV, Joy T, Krishnamurthy A, Agrawal A (2022) Hippocampus and its involvement in Alzheimer\u2019s disease: a review. 3 Biotech 12:55","journal-title":"3 Biotech"},{"key":"4338_CR55","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1007\/s00401-011-0843-x","volume":"122","author":"CY Shao","year":"2011","unstructured":"Shao CY, Mirra SS, Sait HB, Sacktor TC, Sigurdsson EM (2011) Postsynaptic degeneration as revealed by PSD-95 reduction occurs after advanced A\u03b2 and tau pathology in transgenic mouse models of Alzheimer\u2019s disease. Acta Neuropathol 122:285\u2013292","journal-title":"Acta Neuropathol"},{"key":"4338_CR56","doi-asserted-by":"publisher","first-page":"938","DOI":"10.1038\/s41598-018-19154-y","volume":"8","author":"O Poirel","year":"2018","unstructured":"Poirel O, Mella S, Videau C, Ramet L, Davoli MA, Herzog E, Katsel P, Mechawar N, Haroutunian V, Epelbaum J (2018) Moderate decline in select synaptic markers in the prefrontal cortex (BA9) of patients with Alzheimer\u2019s disease at various cognitive stages. Sci Rep 8:938","journal-title":"Sci Rep"},{"key":"4338_CR57","doi-asserted-by":"publisher","first-page":"1150399","DOI":"10.3389\/fnmol.2023.1150399","volume":"16","author":"YJ Lee","year":"2023","unstructured":"Lee YJ, Jeong YJ, Kang EJ, Kang BS, Lee SH, Kim YJ, Kang SS, Suh SW, Ahn EH (2023) GAP-43 closely interacts with BDNF in hippocampal neurons and is associated with Alzheimer\u2019s disease progression. Front Mol Neurosci 16:1150399","journal-title":"Front Mol Neurosci"},{"key":"4338_CR58","doi-asserted-by":"publisher","first-page":"2056","DOI":"10.1021\/pr401202d","volume":"13","author":"S Musunuri","year":"2014","unstructured":"Musunuri S, Wetterhall M, Ingelsson M, Lannfelt L, Artemenko K, Bergquist J, Kultima K, Shevchenko G (2014) Quantification of the brain proteome in Alzheimer\u2019s disease using multiplexed mass spectrometry. J Proteome Res 13:2056\u20132068","journal-title":"J Proteome Res"},{"key":"4338_CR59","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.lfs.2012.12.013","volume":"92","author":"DW DuBois","year":"2013","unstructured":"DuBois DW, Damborsky JC, Fincher AS, Frye GD, Winzer-Serhan UH (2013) Varenicline and nicotine enhance GABAergic synaptic transmission in rat CA1 hippocampal and medial septum\/diagonal band neurons. Life Sci 92:337\u2013344","journal-title":"Life Sci"},{"key":"4338_CR60","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/j.schres.2016.08.031","volume":"178","author":"AC Bridgman","year":"2016","unstructured":"Bridgman AC, Barr MS, Goodman MS, Zomorrodi R, Rajji T, Le Foll B, Chen R, Daskalakis ZJ, George TP (2016) Effects of varenicline on motor cortical plasticity in non-smokers with schizophrenia. Schizophr Res 178:50\u201355","journal-title":"Schizophr Res"},{"key":"4338_CR61","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1038\/npp.2011.238","volume":"37","author":"J-C Shim","year":"2012","unstructured":"Shim J-C, Jung D-U, Jung S-S, Seo Y-S, Cho D-M, Lee J-H, Lee S-W, Kong B-G, Kang J-W, Oh M-K (2012) Adjunctive varenicline treatment with antipsychotic medications for cognitive impairments in people with schizophrenia: a randomized double-blind placebo-controlled trial. Neuropsychopharmacology 37:660\u2013668","journal-title":"Neuropsychopharmacology"},{"key":"4338_CR62","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1038\/npp.2015.305","volume":"41","author":"P Di Ciano","year":"2016","unstructured":"Di Ciano P, Guranda M, Lagzdins D, Tyndale RF, Gamaleddin I, Selby P, Boileau I, Le Foll B (2016) Varenicline-Induced elevation of dopamine in smokers: a preliminary [(11)C]-(+)-PHNO PET study. Neuropsychopharmacology 41:1513\u20131520","journal-title":"Neuropsychopharmacology"},{"key":"4338_CR63","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1111\/j.1476-5381.2009.00529.x","volume":"159","author":"LT Huang","year":"2010","unstructured":"Huang LT, Sherwood JL, Sun YJ, Lodge D, Wang Y (2010) Activation of presynaptic \u03b17 nicotinic receptors evokes an excitatory response in hippocampal CA3 neurones in anaesthetized rats: an in vivo iontophoretic study. Br J Pharmacol 159:554\u2013565","journal-title":"Br J Pharmacol"},{"key":"4338_CR64","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1002\/bies.950191004","volume":"19","author":"M Sheng","year":"1997","unstructured":"Sheng M, Wyszynski M (1997) Ion channel targeting in neurons. BioEssays 19:847\u2013853","journal-title":"BioEssays"}],"container-title":["Neurochemical Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04338-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11064-025-04338-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11064-025-04338-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T05:01:37Z","timestamp":1745557297000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11064-025-04338-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,27]]},"references-count":64,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["4338"],"URL":"https:\/\/doi.org\/10.1007\/s11064-025-04338-6","relation":{},"ISSN":["0364-3190","1573-6903"],"issn-type":[{"value":"0364-3190","type":"print"},{"value":"1573-6903","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,1,27]]},"assertion":[{"value":"9 October 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 January 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 January 2025","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"86"}}